New cancer treatment approach could help immune cells fight tumors longer
- Boosting p53 helped T cells fight melanoma cells in lab tests.
- The approach may help cancer-fighting cells resist exhaustion.
- Animal studies and dose research are still needed.
Researchers at UCLA Health found that temporarily boosting the p53 protein helped specially prepared human T cells resist exhaustion and kill more melanoma cells in laboratory tests. The approach could potentially make some cell-based cancer treatments last longer, addressing a challenge in which T cells lose strength after…